Live Breaking News & Updates on Novocure Company Profile
Stay updated with breaking news from Novocure company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovoCure Limited (NASDAQ:NVCR – Get Free Report) Director W Anthony Vernon sold 964 shares of the business’s stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $23.89, for a total value of $23,029.96. Following the sale, the director now owns 164,833 shares of the company’s stock, valued […] ....
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month […] ....
NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of "Moderate Buy" by Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
NovoCure (NASDAQ:NVCR – Free Report) had its target price trimmed by Wells Fargo & Company from $49.00 to $42.00 in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the medical equipment provider’s stock. Other analysts have also recently issued research reports about the company. HC Wainwright upped […] ....
NovoCure (NASDAQ:NVCR – Get Free Report) had its target price lowered by investment analysts at Wells Fargo & Company from $49.00 to $42.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price objective indicates a potential upside […] ....